Skip to main content

and
  1. No Access

    Article

    Juvenile dermatomyositis resembling late-stage Degos disease with gastrointestinal perforations successfully treated with combination of cyclophosphamide and rituximab: case-based review

    Dermatomyositis (DM) is a multi-system disease that results in chronic inflammation principally of the skin and striated muscle. Small blood vessel injury in the GI tract has been described in dermatomyositis,...

    William Day, Christos Gabriel, Robert E. Kelly Jr. in Rheumatology International (2020)

  2. No Access

    Chapter

    15th International Congress on Antiphospholipid Antibodies Task Force on Pediatric Antiphospholipid Syndrome Report

    In preparation to the 15th International Congress on Antiphospholipid Antibodies (aPL), a multidisciplinary pediatric antiphospholipid syndrome (APS) task force was created in order to review the accumulated k...

    Arzu Soybilgic, Cassyanne L. Aguiar, M. Patricia Massicotte in Antiphospholipid Syndrome (2017)

  3. Article

    Open Access

    Proceedings of the 2016 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scientific Meeting

    P1 Serologic evidence of gut-driven systemic inflammation in juvenile idiopathic arthritis

    Lampros Fotis, Nur Shaikh, Kevin Baszis, Anthony French in Pediatric Rheumatology (2016)

  4. No Access

    Article

    Anaphylaxis to anakinra in a pediatric patient with systemic juvenile idiopathic arthritis successfully treated with canakinumab: a case-based review

    We present the case of a 2-year-old boy with a history of necrotizing enterocolitis (NEC) with ileostomy diagnosed with systemic juvenile idiopathic arthritis (sJIA) at 10 months of age controlled on anti-inte...

    Cassyanne L. Aguiar, Nancy Pan, Alexa Adams, Laura Barinstein in Clinical Rheumatology (2015)

  5. No Access

    Article

    Pediatric Antiphospholipid Syndrome

    Antiphospholipid syndrome (APS) is a multisystem autoimmune condition characterized by vascular thromboses associated with persistently positive antiphospholipid antibodies. There is currently a paucity of dat...

    Cassyanne L. Aguiar, Arzu Soybilgic, Tadej Avcin in Current Rheumatology Reports (2015)